Table 3 PSA testing in Victoria by month
From: The effect of COVID-19 on prostate cancer testing in Australia
Average 2015–2019 (95%CI) | 2020 | Difference (95%CI; and % of average) | Significance | |
|---|---|---|---|---|
January | 12,706 (9890–16,852) | 13,015 | + 309 (− 3004–3622; 102) | P = 0.809 (t = − 0.26) |
February | 14,666 (12,062–16,136) | 15,439 | + 773 (− 1264 to 2811; 105) | P = 0.352 (t = − 1.05) |
March | 16,114 (14,954–17,254) | 14,618 | − 1496 (473 to − 2518; 91) | P = 0.015 (t = 4.06) |
April | 15,133 (14,073–15,909) | 8313 | − 6820 (− 5854 to − 7785; 55) | P < 0.001 (t = 19.61) |
May | 17,674 (15,427–20,242) | 11,803 | − 5871 (− 3686 to − 8055; 67) | P = 0.002 (t = 7.46) |
June | 15,145 (13,953–16,274) | 16,003 | + 858 ( − 292 to 2007; 105) | P = 0.107 (t = − 2.07) |
July | 14,742 (13,124–15,930) | 13,528 | − 1214 (− 91 to − 2519; 91) | P = 0.061 (t = 2.58) |
August | 15,350 (14,347–16,072) | 11,932 | − 3418 (− 4262 to − 2572; 77) | P < 0.001 (t = 11.23) |
September | 14,233 (13,048–15,118) | 14,278 | + 45 (− 920 to 1009; 100) | P = 0.904 (t = − 0.13) |
October | 15,281 (12,650–16,947) | 15,981 | + 700 (− 1285 to 2685;105) | P = 0.383 (t = − 0.98) |
November | 14,902 (14,171–15,302) | 16,015 | + 1113 (512 –1714; 107) | P = 0.007 (t = − 5.14) |
December | 15,110 (13,312–16,799) | 16,501 | + 1391 (226–3009; 109) | P = 0.75 (t = − 2.39) |